Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Neutral and raises the price target from $50 to $70.
Piper Sandler Maintains Neutral on Ceridian HCM Holding, Lowers Price Target to $61
Piper Sandler analyst Arvind Ramnani maintains Ceridian HCM Holding (NYSE:CDAY) with a Neutral and lowers the price target from $85 to $61.